Certain A Shares of Acrobiosystems Co.,Ltd. are subject to a Lock-Up Agreement Ending on 19-OCT-2022.
October 18, 2022
Share
Certain A Shares of Acrobiosystems Co.,Ltd. are subject to a Lock-Up Agreement Ending on 19-OCT-2022. These A Shares will be under lockup for 373 days starting from 11-OCT-2021 to 19-OCT-2022.
Details:
Holding shareholder and actual controller Chen Yiding, Employees' shareholding platform under control of actual controller Tianjin Baipu Saisi Enterprise Management Consulting Partnership Enterprise (Limited Partnership); Tianjin Baipu Jiale Enterprise Management Consulting Partnership Enterprise (Limited Partnership) and Actual controller's person acting in concert Miao Jingyun committed within 36 months after the listing date, shall not transfer nor entrust to others for management direct or indirect shares in the company held prior to this issuance, nor allow the company to repurchase the said shares. If the closing price of the company's share is lower than the issue price for 20 consecutive trading days within 6 months after listing, or if the closing price of the company's share is lower than the issue price for the period ending six months after listing, then the lockup period shall automatically be extended for 6 months.
Shareholder with more than 5% shareholding Yan Changwei and Wang Miaochun, Shareholder with more than 5% shareholding Nanjing Gaoke Xinjun Growth Phase I Equity Investment Partnership Enterprise (LP), other natural person shareholders Shen Qinhua and Other institutional shareholders Hangzhou Jushangyi Equity Investment Fund Partnership (Limited Partnership); Ningbo Lanting Shiling Investment Partnership Enterprise (Limited Partnership); Xinchang Puhua Jingxin Guzhou Health Management Partnership Enterprise (Limited Partnership); Shenzhen Fenxiang Precision Medicine Investment Partnership Enterprise (Limited Partnership); Shuntian Xinrong International Investment (Beijing) Co., Ltd.; Qingdao Rongfeng Kaiyuan Tianyi Equity Investment Partnership Enterprise (Limited Partnership); Tibet Cowin Venture Capital Co., Ltd.; Qingdao Rongfeng Kaiyuan Zhonghe Equity Investment Partnership Enterprise (Limited Partnership) committed within 12 months after the listing date, shall not transfer nor entrust to others for management direct or indirect shares in the company held prior to this issuance, nor allow the company to repurchase the said shares.
Other natural person shareholders Lin Tao committed within 12 months after the listing date, shall not transfer nor entrust to others for management direct or indirect shares in the company held prior to this issuance, nor allow the company to repurchase the said shares. If the closing price of the company's share is lower than the issue price for 20 consecutive trading days within 6 months after listing, or if the closing price of the company's share is lower than the issue price for the period ending six months after listing, then the lockup period shall automatically be extended for 6 months.
Acrobiosystems Co Ltd is a China-based company specializing in providing recombinant protein and other key biological reagent products and technical services. The Company's main products are recombinant proteins and detection services, as well as kits, antibodies, fillers, culture media and other related products. The Company's main products and services are applied to research and development (R&D) and production links such as early drug discovery and verification, drug screening and optimization, development and optimization of diagnostic reagents, preclinical and clinical trials, drug production process and process control (CMC) of tumors, autoimmune diseases, cardiovascular diseases, infectious diseases and other diseases.